🕒 Tuesday 25 August 2026 Tue, 25 Aug 2026

NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.

Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.

Steadfast Group delivered double-digit underlying EBITA growth in FY26 alongside a recommended $6 per share acquisition offer, reflecting a premium of nearly 52%. The insurer broker network continues to expand, supported by technology upgrades and international acquisitions.

Ingenia Communities Group (ASX: INA) reported an 18% rise in FY26 EBIT to $193.4 million, beating guidance, while underlying EPS grew 16% to 35.8 cents. The group also extended its land lease development pipeline to 8,800 sites, underpinning future growth.

CVC Limited posted a net profit after tax of $7.7 million for FY2026, underpinned by a $37.8 million profit from the Laverton sale and a $13.3 million impairment from the Liverpool project. The company paid a special dividend and restructured leadership amid ongoing capital management efforts.

Brisbane Broncos Limited reported a 33% jump in half-year profit before tax to $11.57 million, fuelled by higher crowds, membership, and merchandise sales despite a slight dip in ARLC funding.

Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.

Embelton Limited has reported a solid 20.4% increase in revenue and a 34.7% jump in profit after tax for FY2026, underpinned by a strategic pivot away from residential construction towards infrastructure and social sectors. The company held its dividend steady amid improving cash flow and reduced borrowings.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.

K&S Corporation’s FY2026 profit fell 16% underlying, with a 31% dividend cut reflecting cautious outlook amid economic uncertainty and contract losses.

Lion Rock Minerals (ASX: LRM) has denied holding any undisclosed information that could explain a recent spike in its share price and volume, while confirming it awaits assay results from its ongoing drilling campaign at the Minta Est tenement.

Citigold Corporation Limited has responded to ASX queries, defending its view that alleged breaches of its Forbearance Deed and a shareholder lawsuit are not material. The company also clarified details around a $4.5 million subscription agreement and operational conditions at its Charters Towers project.

Loyal Metals Limited’s acquisition by PT Bumi Resources TBK has reached a key milestone with court approval now official, triggering suspension of Loyal shares on the ASX and setting the stage for scheme consideration payments in early September.

North Stawell Minerals (ASX:NSM) sharpens its focus on replicating the multi-million ounce Stawell Gold Mine, unveiling an 87,300-ounce Wildwood resource and a pipeline of high-grade targets along the Darlington-Caledonia trend in Victoria.

Nex Metals and its Aboriginal partner WTAC have applied for a 100ha lease to build processing infrastructure for the Kookynie Tailings Project, while metallurgical tests show promising gold recovery rates and potential tungsten by-product.

AIX has acquired an 8% holding in AI powerhouse Databricks during its US$5 billion funding round, marking a significant expansion in the trust’s AI-focused portfolio.

humm Group reports a 60% drop in FY26 net profit after tax to $15.7 million, weighed down by irregular legal expenses and credit impairments, while declaring a final dividend and completing major board renewal.

Abacus Group (ASX:ABG) posted a statutory net loss of $74.5 million for FY26, driven by a $122.1 million accounting hit from reclassifying its Storage King stake following management internalisation, while Funds from Operations dipped slightly and distributions were held steady.

Tivan has secured all necessary regulatory and heritage clearances to launch a maiden drilling campaign at Walshy’s Wall, a promising manganese-barite gossan with high-grade fluorite and polymetallic potential in the Northern Territory.

HighCom Limited’s FY26 results reveal a sharp revenue drop and widening loss driven by a US Government shutdown, but a strengthened leadership team and expanded global sales pipeline set the stage for recovery.

Control Bionics has secured MHRA registration for its NeuroStrip device, unlocking commercial supply in Great Britain and launching early trials with leading UK institutions.

WAM Income Maximiser has secured $172.4 million through a multi-part capital raise, increasing its assets by more than half and maintaining a strong fully franked dividend yield.

Piche Resources completed a $2.53 million entitlement offer, raising $728,324 from shareholders, with the underwriter stepping in to cover a $1.85 million shortfall. New shares and options are set to trade from 31 August 2026.

Far East Gold’s independent scoping study for the Idenburg Gold Project spotlights a substantial high-grade inferred resource at Sua, underpinning a clear development pathway and a planned drilling campaign to boost confidence and advance feasibility.